EMA appoints Chief Medical Officer

June 2, 2022

Small flags for the US and EU standing next to each other on a glass desk.

June 1, 2022

Steffen Thirstrup has been appointed as Chief Medical Officer of EMA. In this role, he will provide scientific leadership across EMA and its scientific committees to reinforce the Agency’s capacity to respond to public health challenges and emergencies, and shape EMA’s contribution to EU-health initiatives such as the fight against antimicrobial resistance or Europe’s Beating Cancer Plan. He will also be EMA’s “medical voice” with external stakeholders and explain the considerations that underpin EMA’s regulatory decisions on the benefits and risks of medicinal products.

Prof. Steffen Thirstrup is a medical doctor with a PhD in pharmacology and broad clinical experience in general internal medicine. He has a track record of working with the EU regulatory network. He previously led the Division for Medicines Assessment and Clinical Trials at the Danish Health and Medicines Authority and was the Danish member of EMA’s human medicines committee (CHMP). He was also a member of EMA’s Committee for Advanced Therapies (CAT), the Chairperson of the CHMP’s Respiratory Drafting Group and Co-Chair of the European Commission Working Group on Market Access of Biosimilars.

Prof. Thirstrup is Affiliate Professor at the University of Copenhagen and has worked across a broad range of therapeutic areas throughout different stages of medicine development. Before joining EMA, Prof. Thirstrup worked at the pharmaceutical consultancy company NDA Group, first as a medical advisor and from April 2014 as a board director.

Prof. Thirstrup’s CV and declaration of interest are published on the Agency’s website, together with further information on how EMA handles potential competing interests.

Interested in learning more? Contact us today to find out how we can help not only with your EMA/FDA submissions, but all of your global regulatory needs.


Wayfinding signs with arrows showing 'right' and 'wrong.'

July 13, 2022

EMA Good clinical practice (GCP) inspection procedures

The Good Clinical Practice (GCP) Inspectors Working Group has developed procedures for the coordination, preparation, conduct and reporting of GCP inspections requested by the European Medicines...

Computer generated image of COVID-19

June 15, 2022

EMA adopts first list of critical medicines for COVID-19

News On 7 June 2022, EMA's Medicines Shortages Steering Group (MSSG) adopted the list of critical medicines for the COVID-19 public health emergency. The medicines included in the list are authorised...

Petri dish with bacteria growing.

June 21, 2022

Advice on the designation of antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans - in relation to implementing measures under Article 37(5) of Regulation

Regulatory and Procedural Guideline May 2022 EMA/CVMP/678496/2021-rev Introduction “According to Article 37(5) of Regulation (EU) 2019/6 (‘the Regulation’), the European Commission shall adopt...